Month: December 2020

PBIO News, Options Ideas

Pressure BioSciences, Inc. (OTCMKTS:PBIO)

We are checking in with PBIO this morning, as the company released a PR pertaining to the adoption of its Pressure Cycling Technology (PCT) in coronavirus research, which you’ll find below. We are also still awaiting news of the company’s partnership with Cannaworx, and the launch of its FDA-registered immune booster this month, as indicated by PBIO on December 4th.

Since we began tracking this stock, we have witnessed an impressive trading range as PBIO has moved from a low of 1.80 to yesterday’s new high of 2.75. That works out to an upswing of 53% inside of two weeks, and gives us plenty of reason to be interested in what comes next.

SOUTH EASTON, Mass., Dec. 17, 2020 /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, and food & beverage industries, today announced a remarkable convergence of global research teams announcing pivotal new insights into COVID-19 biology and disease processes. These data point to potential new pathways to next generation diagnostics and treatments. All teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for their critical sample preparation steps, to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in the affected biochemical pathways. (>>View Full PR via OTCMARKETS)
_____

We also have a video presentation on the PBIO chart that we would suggest our readers take a moment to view:


PBIO Video Chart 
_____

For All Investor Inquiries on PBIO,Contact:
Gary Zwetchkenbaum, Plum Tree Consulting LLC
Email: gzplumtree@gmail.com
Phone: (516) 455-7662
Web: plumtreeconsultingllc.com 

The Toro Co. TTC – Recap 

We included the TTC Weekly $90-95 Calls as a possible options trading idea in yesterday morning’s premarket report. With the help of a solid day for the markets as a whole, and the company reporting strong figures for both Q4 and the the 2020 Fiscal Year, we saw instant results.

Here are the total possible intraday gains that were on the table for those targets: 

TTC Weekly $90-95 Calls
$90: 1.15-2.61 (+127%)
$95: .05-.15 (+200%)

_____

Fresh Options Ideas:
JBL Weekly $43.50-45 Calls
LEN Weekly $75.50-77 Calls
ACN Weekly $255-262.50 Calls

Fresh Options Ideas, CURR Investor Webcast Info

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

As we were just pointing out in yesterday morning’s premarket report, CURE was slated to present at LD Micro Main Event Conference yesterday afternoon, and that event went off without a hitch. You can view the company’s full 20-minute presentation by registering at the LD Micro website HERE, navigating to Tuesday’s tab, and looking in the 2PM slot for CURE Pharmaceuticals.

It’s also important to note that CURE will be hosting a Zoom webcast tomorrow at 4PM EST, regarding, among other things, the company’s current strategic positioning.  

You can register to participate in the conference, and/or listen to an archived copy at a later time, at the following link: https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

Direct all investor inquiries on CURR to:

Gary Zwetchkenbaum
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Website: www.plumtreeconsultingllc.com

Fresh Options Ideas 
BOIL Weekly $23-25 Calls
TTC Weekly $90-95 Calls
FDX Weekly $285-290 Calls

Extended Watchlist:
BITW, BLDV, TMXN, DIGAF, MMEDF, CELZ

CURR News Update & More

CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)

The last time we looked in on CURE Pharma, the company had just announced a new brand ambassadorship for the company’s wholly-owned SeraLabs subsidiary with award-winning actress Nicole Kidman. Today, we’re tracking back once again to share a fresh PR.

The news released by CURR yesterday pertains to two key events that are taking place today and Thursday, that will be of interest to both current and potential shareholders alike:

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD Micro Main Event Conference on Tuesday, December 15, 2020 at 11:00 AM Pacific Time. Additionally, the Company will host a video webcast with the investment community on Thursday, December 17, 2020, at 4:00 p.m. Eastern Standard Time

On the Investor Video Webcast, Rob Davidson, CEO of CURE, Nancy Duitch, CEO of wholly-owned subsidiary The Sera Labs and Chief Strategy Officer for the Company, and Mike Redard, CFO of CURE, will present on the Company’s strategic positioning among other topics and will address shareholder questions at the end of the webcast.

To register for this webcast, please use the link below:
https://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg

(>>View Full PR)  

More OTC Runners 

We have recently tagged a number of other OTC traded stocks in our extended watchlist, which have produced significant gain opportunities. It’s very important that our readers don’t simply gloss over these added stocks to track, which are included in most of our premarket reports.

In the case of HAVLF, ZAAG, and AEPT, we just flagged them for observation yesterday morning and they instantly delivered premium chances for a quick profit. ALPP first began appearing in our daily report on November 20th, and has since made an excellent move.

Havn Life Sciences Inc. HAVLF
Range: .62-1.25 (+102%)
_____

ZA Group, Inc. ZAAG
Range: .0225-.038 (+69%)
_____

American Energy Partners, Inc. AEPT
Range: .0081-.0179 (+121%)
_____

Alpine 4 Technologies, Ltd. ALPP 
Range: .152-1.20 (+689%)

Weibo Corp. WB – Update

We tagged the WB Weekly $40-41 Calls and we did see a solid move from the $40’s from 1.55-2.75 (+77%). We’ll continue to track these targets as the week progresses, which should produce further positive activity if the current hopes for another coronavirus stimulus package hold true.

Extended Watchlist:
RVVTF, LKYSF, DFCO, SHMP, AITX, CYTR, HSTRF, PEMTF